1 not yet recruiting, 1 recruiting, 1 terminated. 3 Phase 2, 1 Phase 3.
| Phase | Trials | Status |
|---|---|---|
| Phase 2 | 3 | Not yet recruiting 1, Recruiting 1, Terminated 1 |
| Phase 3 | 1 | Terminated 1 |
Follow Epetraborole: new trials by email Literature Review of Epetraborole trials Research Report on Epetraborole
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Phase 2 Study of Oral Epetraborole in Adults With Polycythemia Vera Epetraborole, Placebo - Polycythemia Vera (SNOMED CT: 109992005) | Phase 2 | Not yet recruiting | AN2 Therapeutics, Inc | 75 | 2026-11-01 | 2026-10-23 |
| Epetraborole in Patients With Mycobacterium Abscessus Lung Disease Epetraborole, Placebo - Mycobacterium Abscessus Infection | Phase 2 | Recruiting | Kevin Winthrop | 84 | 2026-03-30 | 2026-05-06 |
| Study of Epetraborole in Patients With Treatment-refractory MAC Lung Disease Epetraborole, Placebo - MAC Lung Disease, Treatment Refractory MAC Lung Disease | Phase 2 / Phase 3 | Terminated | AN2 Therapeutics, Inc | 177 | 2022-05-20 | 2026-06-10 |
Bone Marrow Diseases (1) · Bone Marrow Neoplasms (1) · Hematologic Diseases (1) · Hematologic Neoplasms (1) · Hemic and Lymphatic Diseases (1) · Infections (1) · Mycobacterium Infections (1) · Mycobacterium Infections, Nontuberculous (1) · Mycobacterium avium-intracellulare Infection (1) · Myeloproliferative Disorders (1) · Neoplasms (1) · Neoplasms by Site (1) · Polycythemia Vera (1) · Respiratory Tract Infections (1)
AN2 Therapeutics, Inc (2) · Kevin Winthrop (1)
Australia (2) · United States (2) · Japan (1) · South Korea (1)